Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer

JTCVS Open(2022)10.1016/j.xjon.2022.02.001Source: DataRank Database

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer is a research paper published in JTCVS Open (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (17)IDs (PubMed, PMC)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Li Ding ORCID,Elizabeth A. David,Scott M. Atay ORCID,Sean C. Wightman ORCID,P. Michael McFadden

Live enrichment

PubMed:36004267 PMC:PMC9390621

NCATS NIH HHS

Grant: UL1 TR001855

NCATS NIH HHS

Grant: UL1 TR000130

National Institutes of Health

Grant: 3UL1TR000130-05S2

Southern California Clinical and Translational Science Institute

National Institutes of Health

Grant: 3UL1TR001855-06A1S1

Southern California Clinical and Translational Science Institute

American Cancer Society

American College of Surgeons

National Center for Advancing Translational Sciences

goldLicense: cc-by-nc-nd

publisherhttp://www.jtcvsopen.org/article/S2666273622000432/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666273622000432?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666273622000432?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9390621

Europe_PMChttps://europepmc.org/articles/PMC9390621

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

SurgeryAdjuvant TherapyMultimodal TherapyNon–small Cell Lung CancerAjcc, American Joint Committee On CancerNsclc, Non–small Cell Lung CancerNcdb, National Cancer DatabaseGuideline Concordant TherapyAdn, Additional Nodules In The Ipsilateral Lung, Same LobeCwi, Chest Wall Invasion Or ResectionGcc, Guideline-Concordant CareS, Surgery AloneS + Cr, Surgery Followed By Chemotherapy With Or Without Radiation TherapyTsz, Tumor Size >5 And ≤7 CmThoracic: Lung Cancer

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequality

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer

FAIR Checklist

Authors (8)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)